Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
October 2021
in “
Microbiology spectrum
”
Studysummary This study proposed a new approach to combat leishmaniasis by targeting host proteins rather than the parasite itself, identifying eight existing drugs as potential treatments despite not having been previously tested on leishmaniasis. Our plain-language summary of this paper — not a Tressless recommendation.
The study used network-based computational methods to identify potential therapeutic targets for the treatment of leishmaniasis, a disease caused by the Leishmania parasite. The researchers analyzed transcription factor regulatory networks of macrophages infected with Leishmania major and identified five host protein-coding gene products as potential therapeutic targets. They found 11 drugs known to interact with these proteins, 3 of which have already been tested against this parasite, while the remaining eight are promising yet-untested antileishmanial therapies. The study suggests that these targets could be used to develop new treatments for leishmaniasis, potentially repurposing existing drugs for a more efficient and cost-effective approach. The document does not specify the number of people involved in the study.
